Log in

Acquired Sales Stock Forecast, Price & News

+0.85 (+29.31 %)
(As of 11/27/2020 10:30 AM ET)
Today's Range
Now: $3.75
50-Day Range
MA: $1.84
52-Week Range
Now: $3.75
Volume422 shs
Average Volume771 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Acquired Sales Corp. does not have significant operations. Previously, it was engaged in selling software licenses and hardware, and the provision of consulting and maintenance services. The company is exploring potential acquisitions of all or a portion of one or more operating businesses involving the manufacture and sale of cannabidiol (CBD)-infused products, such as beverages, muscle/joint rubs, oils, crystals, tinctures, bath bombs, isolate, relief balms, elixirs, body washes, med sticks, lotions, vape pens and cartridges, shatter, and gummies. Acquired Sales Corp. was founded in 1986 and is headquartered in Lake Forest, Illinois.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.44 out of 5 stars

Industry, Sector and Symbol

Industry Conglomerates
Current SymbolOTCMKTS:AQSP



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable
+0.85 (+29.31 %)
(As of 11/27/2020 10:30 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AQSP News and Ratings via Email

Sign-up to receive the latest news and ratings for AQSP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Acquired Sales (OTCMKTS:AQSP) Frequently Asked Questions

How has Acquired Sales' stock price been impacted by COVID-19?

Acquired Sales' stock was trading at $4.15 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, AQSP shares have decreased by 9.6% and is now trading at $3.75.
View which stocks have been most impacted by COVID-19

What stocks does MarketBeat like better than Acquired Sales?

Wall Street analysts have given Acquired Sales a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Acquired Sales wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Acquired Sales' key competitors?

What other stocks do shareholders of Acquired Sales own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Acquired Sales investors own include Spero Therapeutics (SPRO), Cannabix Technologies (BLOZF), Bio-Rad Laboratories (BIO), 28896 (BAMM), Avalara (AVLR), Athersys (ATHX), Arena Pharmaceuticals (ARNA), Aphria (APHA), Aldeyra Therapeutics (ALDX) and Aerojet Rocketdyne (AJRD).

Who are Acquired Sales' key executives?

Acquired Sales' management team includes the following people:
  • Mr. Gerard M. Jacobs J.D., Chairman, CEO & Sec. (Age 64, Pay $52.5k)
  • Mr. William C. Jacobs CPA, Pres, CFO & Treasurer (Age 32, Pay $220k)
  • Mr. Nicholas S. Warrender, Vice Chairman & COO (Age 30)

What is Acquired Sales' stock symbol?

Acquired Sales trades on the OTCMKTS under the ticker symbol "AQSP."

How do I buy shares of Acquired Sales?

Shares of AQSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Acquired Sales' stock price today?

One share of AQSP stock can currently be purchased for approximately $3.75.

What is Acquired Sales' official website?

The official website for Acquired Sales is www.acquiredsalescorp.com.

How can I contact Acquired Sales?

Acquired Sales' mailing address is 31 N Suffolk Ln, LAKE FOREST, IL 60045-4908, United States. The company can be reached via phone at +1-801-7720438.

This page was last updated on 11/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.